Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Genitourinary 1

Conditions

Neoplasms 1 Critical Illness 1 Acute Kidney Injury 1

Interventions

pembrolizumab 28 Docetaxel 21 Gemcitabine 19 Nivolumab 15 Paclitaxel 13 Prednisone 12 Leuprolide 11 pazopanib 10 Radiotherapy 10 Cisplatin 10 Sunitinib 9 Sorafenib 9 Ipilimumab 8 Blood Specimen Collection 8 Bevacizumab 8 avelumab 7 atezolizumab 7 Therapeutics 7 Thalidomide 7 Cyclophosphamide 7 Carboplatin 7 Standard of Care 6 Radiation 6 Mitomycin 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 padeliporfin 5 enzalutamide 5 cemiplimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Spironolactone × Genitourinary × Clear all

NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡